Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2025 (2025-12-31): -615.10%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-357.92%
RETURN ON EQUITY (ROE) AVG 3Y
-280.07%
RETURN ON EQUITY (ROE) AVG 5Y
-196.81%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
TELA Bio, Inc.
Market Cap
$48.77M
Return on Equity (ROE)
N/A
TTM Avg
-357.92%
3Y Avg
-280.07%
5Y Avg
-196.81%
Market Cap
$48.76M
Return on Equity (ROE)
-23.70%
TTM Avg
-170.56%
3Y Avg
-190.10%
5Y Avg
-146.13%
Market Cap
$48.89M
Return on Equity (ROE)
-42.01%
TTM Avg
-2.07%
3Y Avg
11.82%
5Y Avg
5.22%
Market Cap
$48.53M
Return on Equity (ROE)
N/A
TTM Avg
-382.07%
3Y Avg
-282.25%
5Y Avg
-171.00%
Market Cap
$49.25M
Return on Equity (ROE)
-17.84%
TTM Avg
-32.49%
3Y Avg
-23.88%
5Y Avg
-18.14%
Market Cap
$49.45M
Return on Equity (ROE)
N/A
TTM Avg
296.81%
3Y Avg
-175.08%
5Y Avg
-1071.79%
Market Cap
$47.98M
Return on Equity (ROE)
-170.94%
TTM Avg
-132.56%
3Y Avg
-85.15%
5Y Avg
-88.00%
Market Cap
$49.71M
Return on Equity (ROE)
-90.44%
TTM Avg
-163.19%
3Y Avg
-112.62%
5Y Avg
-86.58%
Market Cap
$50.27M
Return on Equity (ROE)
-708.48%
TTM Avg
156.13%
3Y Avg
510.26%
5Y Avg
342.91%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TELA Bio, Inc. (TELA) | $48.77M | N/A | -357.92% | -280.07% | -196.81% |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | -23.70% | -170.56% | -190.10% | -146.13% |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | -42.01% | -2.07% | 11.82% | 5.22% |
| Apollomics, Inc. (APLM)vs › | $48.53M | N/A | -382.07% | -282.25% | -171.00% |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | -17.84% | -32.49% | -23.88% | -18.14% |
| Clene Inc. (CLNN)vs › | $49.45M | N/A | 296.81% | -175.08% | -1071.79% |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | -170.94% | -132.56% | -85.15% | -88.00% |
| INmune Bio, Inc. (INMB)vs › | $49.71M | -90.44% | -163.19% | -112.62% | -86.58% |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | -708.48% | 156.13% | 510.26% | 342.91% |
| biote Corp. (BTMD)vs › | $50.28M | N/A | -24.59% | -14.57% | 93.61% |
ROE
N/A
ROA
-68.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | -615.10% |
| 2025-06-30 | -443.89% |
| 2025-03-31 | -239.72% |
| 2024-12-31 | -132.97% |
| 2024-03-31 | -280.16% |
| 2023-12-31 | -247.15% |
| 2023-09-30 | -143.21% |
| 2023-06-30 | -108.76% |
| 2022-12-31 | -309.65% |
| 2022-09-30 | -184.27% |
| 2022-03-31 | -358.66% |
| 2021-12-31 | -165.57% |
| 2021-09-30 | -117.01% |
| 2021-06-30 | -91.19% |
| 2021-03-31 | -71.26% |
| 2020-12-31 | -58.73% |
| 2020-09-30 | -48.88% |
| 2020-06-30 | -38.64% |
| 2020-03-31 | -97.74% |
| 2019-12-31 | -72.43% |
